NanoViricides is leveraging its unique nanoviricide platform technology to create first-in-class drugs against viruses
NanoViricides is leveraging its unique nanoviricide platform tech…
Jun 21, 2023
proactiveinvestors.com
NanoViricides using unique technology platform to fight against Viruses
NanoViricides using unique technology platform to fight again…
Apr 11, 2023
proactiveinvestors.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Co…
May 1, 2024
marketscreener.com
NanoViricides, Inc. a l'intention de révolutionner le traitement des infections virales telles que le VRS, le COVID, la grippe, etc.
NanoViricides, Inc. a l'intention de révolutionner le traitement des inf…
May 29, 2024
zonebourse.com
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral potential
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral pot…
May 13, 2024
proactiveinvestors.com
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
NanoViricides to Present at the Spartan Capital Investor Conferen…
3 months ago
finanznachrichten.de
NanoViricides to Present at the Life Science Executive Partnering Congress in Boston on September 17, 2025
NanoViricides to Present at the Life Science Executive Partnering Con…
5 months ago
finanznachrichten.de
NanoViricides, Inc.: NanoViricides to Participate in the 2024 EF Hutton …
May 15, 2024
finanznachrichten.de
Nanoviricides Investigates NV-387 for MPOX Treatment Amid Global …
Sep 9, 2024
proactiveinvestors.com
NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectru…
9 months ago
finanznachrichten.de
WHO Extended Global Emergency Status of MPox Epidemic - Develo…
7 months ago
finanznachrichten.de
NanoViricides: Measles Cases Are Increasing Globally; MPox Contin…
9 months ago
finanznachrichten.de
NanoViricides unimpacted by tariffs; sees boost by changes at govern…
10 months ago
proactiveinvestors.co.uk
1:49
NanoViricides Announces Clinical Trial Of Broad-Spectrum Antiviral …
16 viewsJul 19, 2023
DailymotionBenzinga
NanoViricides CEO talks lead drug asset’s potential as MPOX therapy…
Sep 14, 2024
proactiveinvestors.co.uk
1:29
NanoViricides Announces That Clinical Trials Of A Broad-Spectru…
1 viewsJul 5, 2023
DailymotionBenzinga
NanoViricides Reports 'Strong Effectiveness' for COVID Drugs
Mar 2, 2021
thestreet.com
0:33
NanoViricides: New antiviral shows incredible results safety & effectiv…
129 views3 months ago
YouTubeProactive Investors
1:08
$NNVC Reports Their Broad-Spectrum Antiviral Drugs Human …
4 viewsAug 29, 2023
DailymotionBenzinga
NanoViricides, Inc. publie ses résultats financiers pour le premie…
3 months ago
zonebourse.com
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Rai…
3 months ago
finanznachrichten.de
3:56
Innovations and Recognitions in the Healthcare Industry: Updates fro…
2 views1 month ago
YouTubeNewsRamp
NanoViricides makes progress as it completes dosing in Phase 1a CO…
Jan 29, 2024
proactiveinvestors.co.uk
Coronavirus outbreak gives drugmaker's $7.5M stock offering …
Jan 24, 2020
Fox BusinessJonathan Garber
CEO Chat with Anil Diwan, President & Executive Chairman at NanoViri…
5 months ago
MSN
5:32
Cashing in on Coronavirus: Biopharma NanoViricides sees sto…
Jul 14, 2020
CNBCAndrea Day,Jennifer Schlesinger
1:04
NNVC: Phase 2 Trial of NV-387 Antiviral for Mpox | NanoViricides
63 views3 months ago
YouTubeZacks Investment Awareness
1:47
NanoViricides: New drug shows promise RSV, Measles, Flu & COVID
199 views3 months ago
YouTubeProactive Investors
Nanoviricides: COVID-19 therapy trial underway, RSV trial to follow
Jul 12, 2023
proactiveinvestors.co.uk
nanoviricides-testing-oral-gummy-and-syrup-covid-19-treatment-pro…
Jul 12, 2023
proactiveinvestors.co.uk
See more videos
Static thumbnail place holder